Schering-Plough
SGP
#508
Rank
HK$362.00 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Earnings for Schering-Plough (SGP.defunct.2009)

Earnings in 2008: HK$16.05 Billion

According to Schering-Plough's latest financial reports the company's current earnings are N/A. In 2008 the company made an earning of HK$16.05 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Schering-Plough from 1996 to 2008

Annual earnings

Year Earnings Change
2008HK$16.05 B
2006HK$11.62 B198.39%
2005HK$3.89 B-395.83%
2004-HK$1.32 Billion265.22%
2003-HK$0.37 Billion-102.01%
2002HK$17.94 B3.62%
2001HK$17.32 B-5.39%
2000HK$18.30 B
1998HK$15.10 B22.34%
1997HK$12.35 B38.9%
1996HK$8.89 B